Literature DB >> 10783039

Clinical significance of resistant organisms in otitis media.

R Dagan1.   

Abstract

BACKGROUND: Otitis media is an important health care problem of childhood. The bacteriology of otitis media comprises three main pathogens: Streptococcus pneumoniae, nontypable Haemophilus influenzae and Moraxella catarrhalis. Although the prevalence of resistant strains varies geographically and temporally, antimicrobial resistance is widespread and increasing. RESISTANCE TO ANTIBIOTIC DRUGS: Among the risk factors for development of resistance in otitis media are antimicrobial use, young age, day-care attendance and prior hospitalization. The increasing rate of resistance to antibiotic drugs is associated with a decreased rate of successful eradication of pathogens from middle ear fluid, which is associated with clinical failure. A bacteriologic cure rate of 80 to 85% is observed for S. pneumoniae and nontypable H. influenzae when serum concentrations exceed the MIC for 40 to 50% of dosing interval. Comparative trials indicate that some of the beta-lactams can achieve bacteriologic eradication in acute otitis media, although major differences in outcome exist among agents based on pathogen, beta-lactamase status and MIC values. ANTIBIOTIC CHOICE: Overall the choice of antibiotics for treatment of otitis media should take into consideration their in vitro activity against the locally prevalent organisms, especially resistant organisms, and results obtained from studies in which bacteriologic outcome was used as the endpoint.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783039     DOI: 10.1097/00006454-200004000-00033

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Gatifloxacin Therapy in Otitis Media in Children.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2005-05       Impact factor: 3.725

2.  Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study.

Authors:  Kei Kasahara; Koichi Maeda; Keiichi Mikasa; Kenji Uno; Ken Takahashi; Mitsuru Konishi; Eiichiro Yoshimoto; Koichi Murakawa; Eiji Kita; Hiroshi Kimura
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Macrolide-resistant Streptococcus pneumoniae in Canada during 1998-1999: prevalence of mef(A) and erm(B) and susceptibilities to ketolides.

Authors:  D J Hoban; A K Wierzbowski; K Nichol; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

Review 4.  Acute otitis media in children: association with day care centers--antibacterial resistance, treatment, and prevention.

Authors:  David Greenberg; Sigalit Hoffman; Eugene Leibovitz; Ron Dagan
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

5.  Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model.

Authors:  Inga Odenholt; Ingegerd Gustafsson; Elisabeth Löwdin; Otto Cars
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  The effect of vaccination on Streptococcus pneumoniae resistance.

Authors:  Eugene Leibovitz
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 7.  The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion.

Authors:  Marina G Smirnova; John P Birchall; Jeffrey P Pearson
Journal:  Mediators Inflamm       Date:  2004-04       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.